SEC FORM 4/A

SEC FORM 4/ASEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Manwaring Daniel

(Last)

(First)

(Middle)

C/O IMAX CORPORATION

902 BROADWAY, FLOOR 20

(Street)

NEW YORK

10010

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [ IMAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO, IMAX China Holding, Inc.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
03/10/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
common shares (opening balance)								5,078	D
common shares	03/07/2026		M		7,409⁽¹⁾	A	$0.00	12,487	D
common shares	03/07/2026		M		4,666⁽¹⁾	A	$0.00	17,153	D
common shares	03/07/2026		F		4,790⁽²⁾	D	$40.8	12,363	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
restricted share units⁽³⁾	$0.00⁽⁴⁾	03/07/2026		M			7,409	⁽⁵⁾	⁽⁵⁾	common shares	7,409	$0.00⁽⁴⁾	7,410⁽⁸⁾	D
restricted share units⁽³⁾	$0.00⁽⁴⁾	03/07/2026		M			4,666	⁽⁶⁾	⁽⁶⁾	common shares	4,666	$0.00⁽⁴⁾	9,334⁽⁸⁾	D
restricted share units⁽³⁾	$0.00⁽⁴⁾	03/07/2026		A		5,072		⁽⁷⁾	⁽⁷⁾	common shares	5,072	$0.00⁽⁴⁾	5,072⁽⁸⁾	D

Explanation of Responses:

1. Represents the conversion of vested restricted share units into common shares.

2. Mr. Manwaring is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon the conversion of the restricted shares unit transaction.

3. Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.

4. Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.

5. The restricted share units vest and will be converted to common shares in three installments: 7,409 on each of March 7, 2025 and March 7, 2026 and 7,410 on March 7, 2027.

6. The restricted share units vest and will be converted to common shares in three installments: 4,666 on each of March 7, 2026 and March 7, 2027 and 4,668 on March 7, 2028.

7. The restricted share units vest and will be converted to common shares in three installments: 1,690 on each of March 7, 2027 and March 7, 2028 and 1,692 on March 7, 2029.

8. This represents the number of restricted share units for this transaction only. Mr. Manwaring's aggregate remaining restricted share units and common share balances following these transactions are 21,816 and 12,363, respectively.

Remarks:

This Form 4/A amends the Form 4 previously filed on March 10, 2026 (the "Original Form 4") solely to correct the number of shares that were withheld by IMAX Corporation to satisfy tax withholding obligations arising from the vesting of Mr. Manwaring's restricted share units and the resulting amount of securities beneficially owned by Mr. Manwaring following such transaction. Accordingly, this Form 4/A amends the Original Form 4 by correcting: (1) the amount appearing on Table I, Column 4, Row 4 from 5,435 to 4,790; (2) the amount appearing on Table I, Column 5, Row 4 from 11,718 to 12,363; and (3) the number of remaining common share balance in footnote 8 from 11,718 to 12,363. The remaining information in the Original Form 4 is not otherwise amended hereby.

	/s/ Kenneth Weissman (attorney-in-fact for Daniel Manwaring)	04/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)